NEW YORK, July 19 - With $15 million in venture financing, Gene Logic said Thursday it has spun off a new company, Metrigenix, that will develop and commercialize its Flow-thru Chip microarray. 

Metrigenix.will market the Flow-thru Chip as a custom and pre-fabricated gene-based screening array to  pharmaceutical, biotechnology, and other life sciences companies. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.